Estimates Revisions Alamar Biosciences, Inc.
Stocks
ALMR
US0109111056
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.10 USD | -0.88% |
|
+15.31% | - |
| 07-28 | Alamar Biosciences Launches NULISAseq Immune 340 Panel For Comprehensive Profiling Of The Immune Proteome | CI |
| 07-15 | Alamar Biosciences, Inc. Announces Board and Committee Changes | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ALMR Stock
- Consensus Alamar Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
